
Overview
Christopher Ferreri is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Ferreri is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Plasmacytoma, and Agranulocytosis. Dr. Ferreri is currently accepting new patients.
His clinical research consists of co-authoring 43 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Plasmacytoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1021 Morehead Medical Drive, Building 2, Suite 60201, Charlotte, NC 28204
1550 Faulk St., Monroe, NC 28112
Additional Areas of Focus
Dr. Ferreri has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Atrium Health Levine Cancer Institute (Hematology)
Peter Voorhees is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Voorhees is rated as an Elite provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Voorhees is currently accepting new patients.
Atrium Health Levine Cancer Institute (Thoracic-Pulmonary)
Daniel Carrizosa is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Carrizosa is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Lung Cancer, Nasopharyngeal Carcinoma, Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Carrizosa is currently accepting new patients.
Atrium Health Levine Cancer Institute, A Facility Of Carolinas Medical Center
Todd Moore is a Hematologist and an Oncologist in Albemarle, North Carolina. Dr. Moore is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Inflammatory Breast Cancer. Dr. Moore is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Ferreri isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Relapsed Refractory Multiple Myeloma (RRMM)
- Experienced
- Adult T-Cell LeukemiaDr. Ferreri isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Ferreri isExperienced. Learn about Agranulocytosis.
- Autoimmune Hemolytic AnemiaDr. Ferreri isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Follicular LymphomaDr. Ferreri isExperienced. Learn about Follicular Lymphoma.
- Hemophagocytic LymphohistiocytosisDr. Ferreri isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisDr. Ferreri isExperienced. Learn about Histiocytosis.



